Cardlytics Stock Shares Owned By Insiders

CDLX Stock

USD 3.98 0.07 1.73%

Cardlytics fundamentals help investors to digest information that contributes to Cardlytics' financial success or failures. It also enables traders to predict the movement of Cardlytics Stock. The fundamental analysis module provides a way to measure Cardlytics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cardlytics stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cardlytics Company Shares Owned By Insiders Analysis

Cardlytics' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current Cardlytics Shares Owned By Insiders

5.13 %

Most of Cardlytics' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardlytics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Cardlytics Shares Owned By Insiders Driver Correlations

Understanding the fundamental principles of building solid financial models for Cardlytics is extremely important. It helps to project a fair market value of Cardlytics Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Cardlytics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cardlytics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cardlytics' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Long Term Debt Total	Capital Surpluse	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.95	0.32	0.91	0.11	-0.62	0.16	0.77	0.86	-0.54	0.71	0.82	0.8	-0.45	-0.54	0.83	-0.39	0.97	0.71	0.58	0.97	0.06	0.77
Total Stockholder Equity	0.95		0.43	0.84	-0.08	-0.54	0.0	0.64	0.85	-0.58	0.6	0.79	0.57	-0.33	-0.58	0.88	-0.44	0.88	0.76	0.72	0.97	0.21	0.71
Net Tangible Assets	0.32	0.43		0.27	0.25	-0.76	-0.35	0.54	0.71	-0.55	0.62	0.72	0.03	-0.19	-0.58	0.61	-0.5	0.2	0.73	0.0	0.53	0.48	0.7
Current Deferred Revenue	0.91	0.84	0.27		0.27	-0.65	0.36	0.69	0.82	-0.41	0.63	0.8	0.77	-0.54	-0.4	0.62	-0.32	0.95	0.59	0.46	0.85	-0.19	0.82
Net Debt	0.11	-0.08	0.25	0.27		-0.69	0.29	0.47	0.28	-0.17	0.61	0.47	0.46	-0.23	-0.21	-0.12	-0.25	0.23	0.15	-0.51	0.1	-0.48	0.48
Retained Earnings	-0.62	-0.54	-0.76	-0.65	-0.69		-0.04	-0.83	-0.85	0.57	-0.91	-0.94	-0.6	0.41	0.61	-0.58	0.53	-0.61	-0.74	0.04	-0.7	-0.01	-0.93
Accounts Payable	0.16	0.0	-0.35	0.36	0.29	-0.04		0.0	-0.08	0.63	-0.03	0.03	0.42	-0.7	0.64	-0.22	0.67	0.32	-0.39	-0.07	0.0	-0.6	0.1
Long Term Debt	0.77	0.64	0.54	0.69	0.47	-0.83	0.0		0.87	-0.69	0.93	0.83	0.78	-0.36	-0.68	0.75	-0.54	0.72	0.73	0.07	0.79	0.18	0.85
Net Receivables	0.86	0.85	0.71	0.82	0.28	-0.85	-0.08	0.87		-0.73	0.83	0.94	0.63	-0.35	-0.72	0.85	-0.61	0.8	0.91	0.3	0.92	0.2	0.94
Short Term Investments	-0.54	-0.58	-0.55	-0.41	-0.17	0.57	0.63	-0.69	-0.73		-0.65	-0.63	-0.31	-0.3	0.99	-0.64	0.96	-0.44	-0.86	-0.19	-0.64	-0.32	-0.58
Long Term Debt Total	0.71	0.6	0.62	0.63	0.61	-0.91	-0.03	0.93	0.83	-0.65		0.9	0.73	-0.39	-0.68	0.71	-0.56	0.67	0.71	0.1	0.76	0.17	0.87
Capital Surpluse	0.82	0.79	0.72	0.8	0.47	-0.94	0.03	0.83	0.94	-0.63	0.9		0.64	-0.44	-0.66	0.76	-0.55	0.78	0.82	0.29	0.89	0.1	0.96
Total Liab	0.8	0.57	0.03	0.77	0.46	-0.6	0.42	0.78	0.63	-0.31	0.73	0.64		-0.53	-0.3	0.5	-0.18	0.86	0.41	0.16	0.67	-0.26	0.66
Deferred Long Term Liab	-0.45	-0.33	-0.19	-0.54	-0.23	0.41	-0.7	-0.36	-0.35	-0.3	-0.39	-0.44	-0.53		-0.28	-0.34	-0.43	-0.47	0.02	-0.18	-0.39	0.06	-0.51
Short Long Term Debt	-0.54	-0.58	-0.58	-0.4	-0.21	0.61	0.64	-0.68	-0.72	0.99	-0.68	-0.66	-0.3	-0.28		-0.65	0.97	-0.44	-0.85	-0.22	-0.65	-0.33	-0.59
Total Current Assets	0.83	0.88	0.61	0.62	-0.12	-0.58	-0.22	0.75	0.85	-0.64	0.71	0.76	0.5	-0.34	-0.65		-0.45	0.69	0.79	0.59	0.91	0.58	0.72
Short Term Debt	-0.39	-0.44	-0.5	-0.32	-0.25	0.53	0.67	-0.54	-0.61	0.96	-0.56	-0.55	-0.18	-0.43	0.97	-0.45		-0.32	-0.77	-0.11	-0.5	-0.19	-0.49
Intangible Assets	0.97	0.88	0.2	0.95	0.23	-0.61	0.32	0.72	0.8	-0.44	0.67	0.78	0.86	-0.47	-0.44	0.69	-0.32		0.61	0.49	0.9	-0.17	0.74
Common Stock	0.71	0.76	0.73	0.59	0.15	-0.74	-0.39	0.73	0.91	-0.86	0.71	0.82	0.41	0.02	-0.85	0.79	-0.77	0.61		0.28	0.82	0.33	0.79
Property Plant Equipment	0.58	0.72	0.0	0.46	-0.51	0.04	-0.07	0.07	0.3	-0.19	0.1	0.29	0.16	-0.18	-0.22	0.59	-0.11	0.49	0.28		0.59	0.35	0.19
Net Invested Capital	0.97	0.97	0.53	0.85	0.1	-0.7	0.0	0.79	0.92	-0.64	0.76	0.89	0.67	-0.39	-0.65	0.91	-0.5	0.9	0.82	0.59		0.22	0.83
Net Working Capital	0.06	0.21	0.48	-0.19	-0.48	-0.01	-0.6	0.18	0.2	-0.32	0.17	0.1	-0.26	0.06	-0.33	0.58	-0.19	-0.17	0.33	0.35	0.22		0.1
Capital Stock	0.77	0.71	0.7	0.82	0.48	-0.93	0.1	0.85	0.94	-0.58	0.87	0.96	0.66	-0.51	-0.59	0.72	-0.49	0.74	0.79	0.19	0.83	0.1

Click cells to compare fundamentals

Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Competition

Predict Cardlytics

Based on the latest financial disclosure, 5.13% of Cardlytics are shares owned by insiders. This is 49.85% lower than that of the Media sector and significantly higher than that of the Communication Services industry. The shares owned by insiders for all United States stocks is 49.16% higher than that of the company.

Cardlytics Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardlytics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardlytics could also be used in its relative valuation, which is a method of valuing Cardlytics by comparing valuation metrics of similar companies.

Cardlytics is currently under evaluation in shares owned by insiders category among its peers.

Cardlytics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cardlytics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cardlytics' managers, analysts, and investors.

Environmental

Governance

Social

Cardlytics Fundamentals

	Return On Equity	-1.86
	Return On Asset	-0.0762
	Profit Margin	(0.94) %
	Operating Margin	(0.25) %
	Current Valuation	351.11 M
	Shares Outstanding	50.82 M
	Shares Owned By Insiders	5.13 %
	Shares Owned By Institutions	61.52 %
	Number Of Shares Shorted	7.19 M
	Price To Earning	(3.47) X
	Price To Book	2.81 X
	Price To Sales	0.70 X
	Revenue	309.2 M
	Gross Profit	115.42 M
	EBITDA	(99 M)
	Net Income	(134.7 M)
	Cash And Equivalents	157.04 M
	Cash Per Share	4.77 X
	Total Debt	266.11 M
	Debt To Equity	0.42 %
	Current Ratio	0.90 X
	Book Value Per Share	1.38 X
	Cash Flow From Operations	(185 K)
	Short Ratio	7.82 X
	Earnings Per Share	(6.40) X
	Price To Earnings To Growth	(0.24) X
	Target Price	4.4
	Number Of Employees	456
	Beta	1.62
	Market Capitalization	205.83 M
	Total Asset	574.14 M
	Retained Earnings	(1.11 B)
	Working Capital	52.78 M
	Current Asset	81.93 M
	Current Liabilities	52.77 M
	Net Asset	574.14 M

About Cardlytics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cardlytics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardlytics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardlytics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC